Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

648 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dexmedetomidine versus haloperidol for sedation of non-intubated patients with hyperactive delirium during the night in a high dependency unit: study protocol for an open-label, parallel-group, randomized controlled trial (DEX-HD trial).
Minami T, Watanabe H, Kato T, Ikeda K, Ueno K, Matsuyama A, Maeda J, Sakai Y, Harada H, Kuriyama A, Yamaji K, Kitajima N, Kamei J, Takatani Y, Sato Y, Yamashita Y, Mizota T, Ohtsuru S. Minami T, et al. Among authors: yamaji k. BMC Anesthesiol. 2023 Jun 3;23(1):193. doi: 10.1186/s12871-023-02158-1. BMC Anesthesiol. 2023. PMID: 37270483 Free PMC article.
Modifiers of the Risk of Diabetes for Long-Term Outcomes After Coronary Revascularization: CREDO-Kyoto PCI/CABG Registry.
Yamaji K, Shiomi H, Morimoto T, Matsumura-Nakano Y, Ehara N, Sakamoto H, Takeji Y, Yoshikawa Y, Yamamoto K, Kato ET, Imada K, Tada T, Taniguchi R, Nishikawa R, Tada T, Uegaito T, Ogawa T, Yamada M, Takeda T, Eizawa H, Tamura N, Tambara K, Suwa S, Shirotani M, Tamura T, Inoko M, Nishizawa J, Natsuaki M, Sakai H, Yamamoto T, Kanemitsu N, Ohno N, Ishii K, Marui A, Tsuneyoshi H, Terai Y, Nakayama S, Yamazaki K, Takahashi M, Tamura T, Esaki J, Miki S, Onodera T, Mabuchi H, Furukawa Y, Tanaka M, Komiya T, Soga Y, Hanyu M, Domei T, Ando K, Kadota K, Minatoya K, Nakagawa Y, Kimura T; CREDO-Kyoto PCI/CABG Registry Investigators. Yamaji K, et al. JACC Asia. 2022 Apr 12;2(3):294-308. doi: 10.1016/j.jacasi.2021.12.012. eCollection 2022 Jun. JACC Asia. 2022. PMID: 36411876 Free PMC article.
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Patients With Diabetes Undergoing Percutaneous Coronary Intervention.
Yamamoto K, Watanabe H, Morimoto T, Obayashi Y, Natsuaki M, Yamaji K, Domei T, Ogita M, Ohya M, Tatsushima S, Suzuki H, Tada T, Ishii M, Nikaido A, Watanabe N, Fujii S, Mori H, Nishikura T, Suematsu N, Hayashi F, Komiyama K, Shigematsu T, Isawa T, Suwa S, Ando K, Kimura T; STOPDAPT-2 and STOPDAPT-2 ACS Investigators. Yamamoto K, et al. Among authors: yamaji k. JACC Cardiovasc Interv. 2023 Jan 9;16(1):19-31. doi: 10.1016/j.jcin.2022.09.053. Epub 2022 Dec 14. JACC Cardiovasc Interv. 2023. PMID: 36599584 Free article. Clinical Trial.
Prevalence and Effects of High-Intensity Statins for Japanese Patients Presenting With Acute Coronary Syndrome　- A Post Hoc Secondary Analysis of STOPDAPT-2 ACS.
Watanabe H, Morimoto T, Yamamoto K, Obayashi Y, Natsuaki M, Yamaji K, Ogita M, Suwa S, Isawa T, Domei T, Ando K, Tatsushima S, Watanabe H, Oya M, Kadota K, Tokuyama H, Tada T, Sakamoto H, Mori H, Suzuki H, Nishikura T, Wakabayashi K, Kimura T; STOPDAPT-2 ACS Investigators. Watanabe H, et al. Among authors: yamaji k. Circ J. 2023 Apr 25;87(5):657-668. doi: 10.1253/circj.CJ-22-0650. Epub 2022 Dec 8. Circ J. 2023. PMID: 36477579 Free article. Clinical Trial.
Clopidogrel Monotherapy After 1-Month DAPT in Patients With High Bleeding Risk or Complex PCI.
Yamamoto K, Watanabe H, Morimoto T, Obayashi Y, Natsuaki M, Domei T, Yamaji K, Suwa S, Isawa T, Watanabe H, Yoshida R, Sakamoto H, Akao M, Hata Y, Morishima I, Tokuyama H, Yagi M, Suzuki H, Wakabayashi K, Suematsu N, Inada T, Tamura T, Okayama H, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Morino Y, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 and STOPDAPT-2 ACS Investigators. Yamamoto K, et al. Among authors: yamaji k. JACC Asia. 2023 Jan 10;3(1):31-46. doi: 10.1016/j.jacasi.2022.09.011. eCollection 2023 Feb. JACC Asia. 2023. PMID: 36873770 Free PMC article.
Impact of Institutional and Operator Volume on Short-Term Outcomes of Percutaneous Coronary Intervention: A Report From the Japanese Nationwide Registry.
Inohara T, Kohsaka S, Yamaji K, Amano T, Fujii K, Oda H, Uemura S, Kadota K, Miyata H, Nakamura M; J-PCI Registry Investigators. Inohara T, et al. Among authors: yamaji k. JACC Cardiovasc Interv. 2017 May 8;10(9):918-927. doi: 10.1016/j.jcin.2017.02.015. JACC Cardiovasc Interv. 2017. PMID: 28473114 Free article.
Characteristics and outcomes of patients with no standard modifiable risk factors undergoing primary revascularization for acute myocardial infarction: Insights from the nationwide Japanese percutaneous coronary intervention registry.
Saito Y, Inohara T, Kohsaka S, Wada H, Takamisawa I, Yamaji K, Amano T, Kobayashi Y, Kozuma K; J-PCI Registry Investigators. Saito Y, et al. Among authors: yamaji k. Am Heart J. 2023 Apr;258:69-76. doi: 10.1016/j.ahj.2023.01.009. Epub 2023 Jan 13. Am Heart J. 2023. PMID: 36642224
Statin Discontinuation After Coronary Revascularization.
Yamamoto K, Morimoto T, Natsuaki M, Shiomi H, Ogita M, Tada T, Toyota T, Nakatsuma K, Ehara N, Yamaji K, Tazaki J, Toyofuku M, Yokomatsu T, Kadota K, Ando K, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-3 Investigators. Yamamoto K, et al. Among authors: yamaji k. Am J Cardiol. 2023 Nov 15;207:479-489. doi: 10.1016/j.amjcard.2023.09.047. Epub 2023 Oct 3. Am J Cardiol. 2023. PMID: 37798170
648 results